Higher Folic Acid By Solaray Predicts Moderately Lower Guiltiness for Population

Higher Folic Acid By Solaray Predicts Moderately Lower Guiltiness for Population

Contents

Variables

A
Folic Acid by Solaray 32
A
Guiltiness 2319

Categories

A
Treatments 9356
A
Emotions 2028

Actions

A
Join Study
A
Your Data

Tags

High Confidence
Weak Effect Size
Negative Relationship
Population Study
cause image gauge image effect image
Participants reported a 27.5% average decrease in Guiltiness following above average Folic Acid By Solaray.

Abstract

Guiltiness was generally 20.1% lower than average after 800 micrograms of Folic Acid By Solaray per 21 days.

Aggregated data from 1 study participants suggests with a HIGH degree of confidence (p=0.001, 95% CI -0.463 to -0.163) that Folic Acid By Solaray has a moderately negative predictive relationship (R=-0.313) with Guiltiness.

The highest quartile of Guiltiness measurements were observed following an average 112 micrograms Folic Acid By Solaray.

The lowest quartile of Guiltiness measurements were observed following an average 386 micrograms of Folic Acid By Solaray.

After an onset delay of 30 minutes, Guiltiness is typically 5% lower than average over the 21 days following around 386 micrograms of Folic Acid By Solaray Folic Acid By Solaray.

Keywords: Folic Acid By Solaray, Guiltiness, N-of-1 trials, real-world evidence, causal inference, observational study

Preliminary: Based on 1 participants. Results may change as more data is collected.

Results

Primary Findings

Analysis of 75 paired observations from 1 participants revealed a moderate reduction in Guiltiness following above-average Folic Acid By Solaray exposure.

-20.1%
Change from Baseline
Moderate effect on Guiltiness
0.12
Predictor Impact Score
Weak evidence for causal relationship

Supporting Statistics

Low
Confidence
-0.313
Correlation (r)
p = 0.514
Significance
z = 0.62
Effect Magnitude
φ = 1.00
Temporality

What This Means

When participants had above-average Folic Acid By Solaray:

  • Guiltiness decreased by 20.1% on average
  • Temporal analysis supports Folic Acid By Solaray as the predictor (not the outcome)

Interpreting the Predictor Impact Score

The Predictor Impact Score (PIS) integrates multiple Bradford Hill causal criteria into a single metric. Use this guide to interpret the score:

PIS Range Interpretation Recommended Action
≥ 0.5 Strong evidence High priority for RCT validation
0.3 - 0.5 Moderate evidence Consider for experimental investigation
0.1 - 0.3 Weak evidence Monitor for additional data
< 0.1 Insufficient evidence Low priority; may be noise

Note: PIS is a prioritization heuristic, not proof of causation. High scores indicate relationships worth investigating, not confirmed causal effects. With only 1 participants, these scores are preliminary and will become more reliable as additional data is collected.

Optimal Daily Values (Precision Dosing)

Based on the observed relationship, we can estimate the predictor values associated with the best and worst outcomes. These values enable personalized dosing recommendations.

⚠️ Preliminary Data: With 1 participants and 75 observations, these optimal values are preliminary estimates. As more data is collected, precision will improve significantly.

0.0 mcg
Value Predicting Higher Guiltiness
Average Folic Acid By Solaray when Guiltiness exceeded its mean
800.0 mcg
Value Predicting Lower Guiltiness
Average Folic Acid By Solaray when Guiltiness was below its mean

What This Suggests

Guiltiness tended to be lowest (best) when Folic Acid By Solaray was around 800.0 mcg.

Important: These values reflect correlations, not guaranteed causal effects. Individual responses may vary. Use as a starting point for personal experimentation, not as a definitive prescription. Consult healthcare providers before making treatment decisions.

Population Correlation

Folic Acid By Solaray Distribution

Guiltiness Distribution

Relationship Analysis

Statistical Summary

Relationship Statistics

Property Value
Cause Variable Name Folic Acid By Solaray
Effect Variable Name Guiltiness
Sinn Predictive Coefficient 0.12494846950619
Confidence Level HIGH
Confidence Interval 0.14954119553734
Forward Pearson Predictive Coefficient -0.313
Critical T Value 1.664
Average Folic Acid By Solaray Over Previous 21 days Before ABOVE Average Guiltiness 112 micrograms
Average Folic Acid By Solaray Over Previous 21 days Before BELOW Average Guiltiness 386 micrograms
Duration of Action 21 days
Effect Size moderately negative
Number of Paired Measurements 75
Optimal Pearson Product 0.22398664715674
P Value 0.001
Statistical Significance 0.5137
Strength of Relationship 0.14954119553734
Study Type population
Analysis Performed At 2026-01-04
Number of Participants 1

Folic Acid by Solaray Info

Property Value
Variable Name Folic Acid By Solaray
Aggregation Method MEAN
Analysis Performed At 2020-09-22
Duration of Action 21 days
Filling Value 0
Kurtosis 1.9863095840515
Mean 636.84 micrograms
Median 800 micrograms
Minimum Allowed Value 0 micrograms
Number of Aggregate Predictors 0
Number of Aggregate Outcomes 32
Number of Measurements 69
Number of Measurements (including those generated by tagged, joined, or child variables) 69
Public true
Onset Delay 30 minutes
Standard Deviation 621.48311874421
Unit Micrograms
User Variables 2
UPC 076280043525
Variable Category Treatments
Variable ID 86637
Variance 386241.26688403

Guiltiness Info

Property Value
Variable Name Guiltiness
Aggregation Method MEAN
Analysis Performed At 2022-09-29
Duration of Action 24 hours
Kurtosis 2.2615389805518
Maximum Allowed Value 5 out of 5
Mean 2.365934400949 out of 5
Median 2.2960569395018 out of 5
Minimum Allowed Value 1 out of 5
Number of Aggregate Predictors 2056
Number of Aggregate Outcomes 263
Number of Measurements 31621
Number of Measurements (including those generated by tagged, joined, or child variables) 31621
Public true
Onset Delay 0 seconds
Standard Deviation 0.5743531754414
Unit 1 to 5 Rating
User Variables 1787
UPC 0
Variable Category Emotions
Variable ID 1335
Variance 0.72121328198661

Introduction

Background

Folic Acid By Solaray (Treatments) and Guiltiness (Emotions) are both important factors in understanding human health and well-being. This study investigates the relationship between these two variables using real-world observational data.

Traditional randomized controlled trials (RCTs), while the gold standard for causal inference, are often impractical, expensive, or unethical for studying many health relationships. Aggregated N-of-1 observational studies offer a complementary approach that leverages within-subject comparisons across large populations to identify meaningful patterns.

Research Question

Does Folic Acid By Solaray affect Guiltiness?

Additionally, we seek to determine:

  1. What is the direction and magnitude of any effect?
  2. How confident can we be in this relationship based on the available data?
  3. What are the optimal levels of Folic Acid By Solaray for maximizing Guiltiness?

Study Objective

The objective of this study is to determine the nature of the relationship (if any) between Folic Acid By Solaray and Guiltiness. Additionally, we attempt to determine the Folic Acid By Solaray values most likely to produce optimal Guiltiness values.

Study Overview

This is a population-level observational study using aggregated N-of-1 methodology. By aggregating individual N-of-1 experiments, we can identify population-level patterns while accounting for the substantial individual variation that exists in most health relationships. Effect sizes are reported as percent change from baseline, enabling intuitive interpretation and comparison across different measures.

Full Methodology: Framework for Real-World Evidence-Based Pharmacovigilance: Aggregated N-of-1 Trials for Quantifying Treatment Effects

Discussion

Interpretation of Findings

Participants experienced a 20.1% reduction in Guiltiness following above-average Folic Acid By Solaray exposure. The Predictor Impact Score (PIS) of 0.12 indicates weak evidence for a causal relationship.

Statistical Significance

Using a two-tailed t-test with alpha = 0.05, it was determined that the change in Guiltiness is statistically significant at a 95% confidence interval. The p-value of 0.5137 indicates there is less than a 51.37% probability that this result occurred by chance.

After treatment, a 27.5% decrease (-0.33 out of 5) from the mean baseline 1.65 out of 5 was observed. The relative standard deviation at baseline was 32.5%. The observed change was 0.616254 times the standard deviation.

A common rule of thumb considers a change greater than twice the baseline standard deviation on two separate pre-post experiments may be considered significant. This occurrence would have only a 5% likelihood of resulting from random fluctuation (a p-value < 0.05).

T-Test Details
Observed t-value: 3.761
Critical t-value: 1.664

Since t = 3.76 > 1.66, we reject the null hypothesis.

Biological Plausibility

A plausible bio-chemical mechanism between predictor and outcome is critical for interpreting observational findings. This is where human judgment excels beyond statistical analysis.

Based on community responses so far, 1 person feels that there is a plausible mechanism of action and 0 feel that any relationship observed between Folic Acid By Solaray and Guiltiness is coincidental.

Bradford Hill Criteria Assessment

The Bradford Hill criteria provide a framework for assessing causality in observational studies. Our methodology operationalizes six of the nine criteria through the Predictor Impact Score (PIS):

Criterion How Addressed Metric
Strength Effect size magnitude Percent change from baseline (Δ%), z-score
Consistency Cross-participant replication Number of users (N), number of pairs (n)
Temporality Predictor precedes outcome Temporality factor (φ), onset delay (δ > 0)
Biological Gradient Dose-response relationship Gradient coefficient (φgradient)
Plausibility Biological mechanism assessment Community votes on mechanism plausibility
Specificity Category appropriateness Interest factor (finterest)

Predictor Impact Score (PIS)

The PIS integrates multiple Bradford Hill criteria into a composite metric quantifying how reliably a predictor affects an outcome. Higher scores indicate stronger evidence:

Population-Level PIS:

$$\text{PIS}_{\text{agg}} = |r_{\text{forward}}| \cdot w \cdot \phi_{\text{users}} \cdot \phi_{\text{pairs}} \cdot \phi_{\text{change}} \cdot \phi_{\text{gradient}}$$

Where φ-factors are saturation functions approaching 1 as evidence accumulates:

  • φusers = 1 - e-N/10 (user saturation)
  • φpairs = 1 - e-n/nsig (pair saturation)
  • φchange = 1 - e-Δspread/Δsig (effect spread saturation)
  • w = weighted average of plausibility votes

Temporality Assessment

We assess evidence for correct causal direction using the temporality factor:

$$\phi_{\text{temporal}} = \frac{|r_{\text{forward}}|}{|r_{\text{forward}}| + |r_{\text{reverse}}|}$$

Values approaching 1 indicate the predictor precedes the outcome (supporting causation); values near 0.5 suggest ambiguous directionality; values near 0 suggest reverse causation or confounding by indication.

Limitations

As with any observational study, correlation does not prove causation. Key limitations include:

  • Unmeasured confounders: Variables not tracked may influence results
  • Self-selection bias: Health trackers may differ from the general population
  • Measurement error: Self-reported data may contain recall bias
  • Confounding by indication: Sicker individuals may use more treatments

However, within-subject comparison and temporal precedence analysis partially mitigate these limitations. If the relationship is merely coincidental, as participants independently modify their Folic Acid By Solaray values, the observed strength will decline over time. Spurious correlations naturally dissipate as more data is collected.

Future Directions

Future research should examine:

  • Subgroup analyses to identify individual differences in response
  • Potential confounders and mediators of the observed relationship
  • Optimal dosing and timing for Folic Acid By Solaray
  • Confirmation through prospective or randomized designs
  • Biological mechanisms underlying the observed effects

Conclusion

📊 Preliminary Findings: With 1 participants, these results are based on limited data. Effect sizes and confidence will improve as more participants contribute data. Consider these findings directional rather than definitive.

Above-average Folic Acid By Solaray was associated with a 20.1% reduction in Guiltiness—a moderate effect. The Predictor Impact Score of 0.12 indicates this relationship is warranting continued monitoring.

Bottom Line: Based on a PIS of 0.12 and a 20.1% effect size, this relationship shows weak evidence. Additional observational data is recommended before investing in experimental validation. Note: These conclusions may strengthen or change direction as more data is collected.

These findings contribute to our understanding of how Folic Acid By Solaray may influence Guiltiness in real-world conditions. While preliminary, these results may inform future research directions. As more participants contribute data, the reliability and precision of these findings will improve substantially.

Help End Unnecessary Suffering

Current clinical trials are 82x more expensive than necessary and take 17 years to bring treatments to market. Pragmatic trials integrated into standard healthcare could reduce costs from $41,000 to $500 per participant and compress timelines to just 2 years. Learn how redirecting just 1% of global military spending could accelerate cures for the 2 billion people suffering from treatable diseases.

Make Suffering Optional

Methods

Study Design

This study is based on data donated by 1 participants. Thus, the study design is equivalent to the aggregation of 1 separate n=1 observational natural experiments.

This within-subject design is powerful because it controls for all stable individual characteristics (genetics, baseline health status, socioeconomic factors) that might otherwise confound the relationship between variables.

Data Analysis

Temporal Assumptions

The analysis incorporates temporal assumptions about the relationship between variables:

  • Onset Delay: It was assumed that 30 minutes would pass before a change in Folic Acid By Solaray would produce an observable change in Guiltiness.
  • Duration of Action: It was assumed that Folic Acid By Solaray could produce an observable change in Guiltiness for as much as 21 days after the stimulus event.

Statistical Methods

For each participant, we calculated the Pearson correlation coefficient between Folic Acid By Solaray values and subsequent Guiltiness values. Individual correlations were then aggregated using Fisher's z-transformation to produce a population-level estimate:

Individual Correlation:

$$r_i = \frac{\sum(x_{ij} - \bar{x}_i)(y_{ij} - \bar{y}_i)}{\sqrt{\sum(x_{ij} - \bar{x}_i)^2 \sum(y_{ij} - \bar{y}_i)^2}}$$

Fisher's Z-Transformation:

$$z_i = \frac{1}{2} \ln\left(\frac{1 + r_i}{1 - r_i}\right)$$

Aggregated Correlation:

$$\bar{r} = \tanh(\bar{z}) \quad \text{where} \quad \bar{z} = \frac{1}{N}\sum_{i=1}^{N} z_i$$

Effect Size Calculation

Effect sizes are reported as percent change from baseline. For each participant, we compare the outcome following above-average predictor values to the overall baseline outcome:

$$\Delta\%_{\text{baseline}} = \frac{\bar{O}_{\text{follow-up}} - \bar{O}_{\text{baseline}}}{\bar{O}_{\text{baseline}}} \times 100$$

Effect Magnitude (Z-Score)

To assess effect magnitude relative to natural variability, we calculate the z-score:

$$z = \frac{|\Delta\%_{\text{baseline}}|}{\text{RSD}_{\text{baseline}}}$$

where RSDbaseline is the relative standard deviation of outcome during baseline period

A z-score > 2 indicates statistical significance (p < 0.05), meaning the observed change exceeds typical baseline fluctuation and is unlikely due to random variation.

Statistical Significance

Correlation significance is assessed using a two-tailed t-test:

$$t = \frac{r\sqrt{n-2}}{\sqrt{1-r^2}}$$

We reject the null hypothesis (ρ = 0) at α = 0.05 when |t| exceeds the critical value, providing statistical evidence that the observed relationship is not due to chance.

Data Sources

Folic Acid By Solaray data was primarily collected using QuantiModo. QuantiModo allows you to easily track mood, symptoms, or any outcome you want to optimize in a fraction of a second. You can also import your data from over 30 other apps and devices. QuantiModo then analyzes your data to identify which hidden factors are most likely to be influencing your mood or symptoms.

Guiltiness data was primarily collected using QuantiModo. QuantiModo allows you to easily track mood, symptoms, or any outcome you want to optimize in a fraction of a second. You can also import your data from over 30 other apps and devices. QuantiModo then analyzes your data to identify which hidden factors are most likely to be influencing your mood or symptoms.

Data Quality

Data quality measures were applied to ensure reliable results:

  • Minimum Data Requirement: Only participants with sufficient paired observations were included in the analysis.
  • Outlier Handling: Extreme values were winsorized to reduce the influence of measurement errors.
  • Missing Data: Days with missing values were handled using appropriate filling strategies based on the variable type.
  • Test User Exclusion: Test accounts and invalid users were excluded from all analyses.

Principal Investigator

Program & Methods

Mike P. Sinn
Sinn, M. P.

Designed and implemented data collection, aggregation, causal inference pipeline, and automated study generation framework. Developed the Predictor Impact Score methodology operationalizing Bradford Hill criteria for ranking causal relationships in observational data. When he tells people this at parties, they usually say they have to go check on their car.

Individual study outputs are automated, reproducible, and open to external audit. (Which I would seriously recommend.)

Contact

Cite This Study

APA Format
Sinn, M. P. (2026). Causal Analysis: Does Folic Acid By Solaray Affect Guiltiness?. The Journal of Citizen Science. https://studies.crowdsourcingcures.org/study/cause-86637-effect-1335-population-study
BibTeX 
@misc{sinn_cause_86637_effect_1335_population_study_2026,
  author = {Sinn, Mike P.},
  title = {Causal Analysis: Does Folic Acid By Solaray Affect Guiltiness?},
  year = {2026},
  publisher = {The Journal of Citizen Science},
  url = {https://studies.crowdsourcingcures.org/study/cause-86637-effect-1335-population-study},
  note = {Accessed: January 9, 2026}
}
Chicago/Turabian
Sinn, Mike P. "Causal Analysis: Does Folic Acid By Solaray Affect Guiltiness?." The Journal of Citizen Science. Accessed January 9, 2026. https://studies.crowdsourcingcures.org/study/cause-86637-effect-1335-population-study.
Harvard
Sinn, M.P., 2026. Causal Analysis: Does Folic Acid By Solaray Affect Guiltiness?. [Aggregated N-of-1 Study] The Journal of Citizen Science. Available at: https://studies.crowdsourcingcures.org/study/cause-86637-effect-1335-population-study [Accessed January 9, 2026].

Study Type: Aggregated N-of-1 Observational Mega-Study
Evidence Level: Level II (Real-World Evidence)
Methodology: Bradford Hill Criteria with Predictor Impact Score (PIS)

References

This framework was originally developed in 2013 based on the Bradford Hill criteria. Subsequent literature has independently validated similar approaches to causal inference from observational data:

  1. Hill, A.B. (1965). The environment and disease: association or causation? Proceedings of the Royal Society of Medicine, 58(5), 295-300. [Bradford Hill criteria]
  2. Lillie, E.O., et al. (2011). The n-of-1 clinical trial: the ultimate strategy for individualizing medicine? Personalized Medicine, 8(2), 161-173. [N-of-1 methodology]
  3. Pearl, J. (2009). Causality: Models, Reasoning, and Inference . Cambridge University Press. [Causal inference]
  4. Hernán, M.A., & Robins, J.M. (2020). Causal Inference: What If . Chapman & Hall/CRC. [Free textbook]
  5. FDA (2018). Framework for FDA's Real-World Evidence Program . U.S. Food and Drug Administration. [Regulatory context]
  6. Duan, N., et al. (2013). Single-patient (n-of-1) trials: a pragmatic clinical decision methodology . Journal of Clinical Epidemiology, 66(8), S21-S28.
  7. Platt, R., et al. (2018). The FDA Sentinel Initiative—an evolving national resource . New England Journal of Medicine, 379(22), 2091-2093.

This information is for research and educational purposes only, not medical advice. Consult a healthcare provider before making health decisions. Terms of Service

LinkedIn Reddit